Protocols
1 protocol(s) meet the specified criteria
Drug: IBRUTINIB
Protocol No.TitleStatus
NCI9922A Phase 2 Study of Ibrutinib (PCI-32765) in Refractory Distant Metastatic Cutaneous Melanoma: Correlation of Biomarkers with Response and Resistance Open